Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.

UK Innovate will unite the Office of Technology Commercialization and several other initiatives as the university reveals it launched six new spinouts.

The GV-backed medical supplies distribution service received the money from new and returning investors at a $2.75bn valuation.

SBCVC helped supply $46.5m for smart industrial software developer Ones while e-commerce marketplace aggregator 10club raised $40m in a PDC and HeyDay-backed seed round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The diagnostic and therapeutic isotope producer secured series C-5 funding, which will be used to accelerate the development of new fusion-based technology applications.

Gilead Sciences is co-leading a $75m PIPE deal for the coronavirus drug developer, which is set take the place on Nasdaq held by FS Development Corp II later this year.

Existing investor Hearst backed healthcare services portal Wellthy in a series B round which pushed its overall funding to about $45m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.